vs

Side-by-side financial comparison of DMC Global Inc. (BOOM) and Health Catalyst, Inc. (HCAT). Click either name above to swap in a different company.

DMC Global Inc. is the larger business by last-quarter revenue ($143.5M vs $74.7M, roughly 1.9× Health Catalyst, Inc.). DMC Global Inc. runs the higher net margin — -7.8% vs -121.9%, a 114.1% gap on every dollar of revenue. On growth, DMC Global Inc. posted the faster year-over-year revenue change (-5.8% vs -6.2%). Health Catalyst, Inc. produced more free cash flow last quarter ($9.6M vs $9.6M). Over the past eight quarters, Health Catalyst, Inc.'s revenue compounded faster (-0.0% CAGR vs -7.3%).

DMC Mining Services is a mining services contractor founded in 1980 operating in Canada, the United States, Chile, and Mongolia

Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company based in Coral Gables, Florida, United States. The company develops medicines for rare diseases, including the phosphate salt of amifampridine for the treatment of Lambert–Eaton myasthenic syndrome (LEMS). The drug is referred to under the trade name Firdapse, which was approved by the FDA for approved use in children 6 years and older with LEMS in addition to the prior approval for use in adults with LEMS on November 28, 2018. Fir...

BOOM vs HCAT — Head-to-Head

Bigger by revenue
BOOM
BOOM
1.9× larger
BOOM
$143.5M
$74.7M
HCAT
Growing faster (revenue YoY)
BOOM
BOOM
+0.4% gap
BOOM
-5.8%
-6.2%
HCAT
Higher net margin
BOOM
BOOM
114.1% more per $
BOOM
-7.8%
-121.9%
HCAT
More free cash flow
HCAT
HCAT
$5.0K more FCF
HCAT
$9.6M
$9.6M
BOOM
Faster 2-yr revenue CAGR
HCAT
HCAT
Annualised
HCAT
-0.0%
-7.3%
BOOM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BOOM
BOOM
HCAT
HCAT
Revenue
$143.5M
$74.7M
Net Profit
$-11.2M
$-91.0M
Gross Margin
17.1%
Operating Margin
-7.8%
-115.3%
Net Margin
-7.8%
-121.9%
Revenue YoY
-5.8%
-6.2%
Net Profit YoY
-3871.6%
-340.3%
EPS (diluted)
$-0.60
$-1.29

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BOOM
BOOM
HCAT
HCAT
Q4 25
$143.5M
$74.7M
Q3 25
$151.5M
$76.3M
Q2 25
$155.5M
$80.7M
Q1 25
$159.3M
$79.4M
Q4 24
$152.4M
$79.6M
Q3 24
$152.4M
$76.4M
Q2 24
$171.2M
$75.9M
Q1 24
$166.9M
$74.7M
Net Profit
BOOM
BOOM
HCAT
HCAT
Q4 25
$-11.2M
$-91.0M
Q3 25
$-3.1M
$-22.2M
Q2 25
$116.0K
$-41.0M
Q1 25
$677.0K
$-23.7M
Q4 24
$296.0K
$-20.7M
Q3 24
$-101.3M
$-14.7M
Q2 24
$4.0M
$-13.5M
Q1 24
$2.6M
$-20.6M
Gross Margin
BOOM
BOOM
HCAT
HCAT
Q4 25
17.1%
Q3 25
21.7%
52.6%
Q2 25
23.6%
Q1 25
25.9%
Q4 24
20.8%
Q3 24
19.8%
47.5%
Q2 24
27.1%
Q1 24
25.4%
Operating Margin
BOOM
BOOM
HCAT
HCAT
Q4 25
-7.8%
-115.3%
Q3 25
0.4%
-22.9%
Q2 25
2.5%
-46.0%
Q1 25
4.1%
-25.4%
Q4 24
-0.5%
-22.0%
Q3 24
-97.7%
-17.9%
Q2 24
6.8%
-20.8%
Q1 24
4.0%
-30.5%
Net Margin
BOOM
BOOM
HCAT
HCAT
Q4 25
-7.8%
-121.9%
Q3 25
-2.0%
-29.1%
Q2 25
0.1%
-50.8%
Q1 25
0.4%
-29.9%
Q4 24
0.2%
-26.0%
Q3 24
-66.5%
-19.3%
Q2 24
2.3%
-17.8%
Q1 24
1.5%
-27.6%
EPS (diluted)
BOOM
BOOM
HCAT
HCAT
Q4 25
$-0.60
$-1.29
Q3 25
$-0.10
$-0.32
Q2 25
$-0.24
$-0.59
Q1 25
$0.04
$-0.35
Q4 24
$-0.18
$-0.33
Q3 24
$-8.27
$-0.24
Q2 24
$0.24
$-0.23
Q1 24
$0.01
$-0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BOOM
BOOM
HCAT
HCAT
Cash + ST InvestmentsLiquidity on hand
$31.9M
$95.7M
Total DebtLower is stronger
$50.6M
$153.3M
Stockholders' EquityBook value
$242.1M
$245.8M
Total Assets
$635.8M
$502.6M
Debt / EquityLower = less leverage
0.21×
0.62×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BOOM
BOOM
HCAT
HCAT
Q4 25
$31.9M
$95.7M
Q3 25
$26.4M
$91.5M
Q2 25
$12.4M
$97.3M
Q1 25
$14.7M
$342.0M
Q4 24
$14.3M
$392.0M
Q3 24
$14.5M
$387.3M
Q2 24
$14.6M
$308.3M
Q1 24
$20.4M
$327.8M
Total Debt
BOOM
BOOM
HCAT
HCAT
Q4 25
$50.6M
$153.3M
Q3 25
$56.5M
$153.1M
Q2 25
$58.7M
$153.0M
Q1 25
$72.4M
$382.9M
Q4 24
$70.8M
$382.4M
Q3 24
$74.2M
$345.0M
Q2 24
$84.1M
Q1 24
$88.0M
Stockholders' Equity
BOOM
BOOM
HCAT
HCAT
Q4 25
$242.1M
$245.8M
Q3 25
$253.0M
$331.9M
Q2 25
$253.9M
$347.5M
Q1 25
$253.9M
$376.8M
Q4 24
$251.0M
$365.2M
Q3 24
$256.5M
$355.0M
Q2 24
$416.0M
$357.0M
Q1 24
$409.9M
$357.2M
Total Assets
BOOM
BOOM
HCAT
HCAT
Q4 25
$635.8M
$502.6M
Q3 25
$644.1M
$587.1M
Q2 25
$645.0M
$616.2M
Q1 25
$670.6M
$891.5M
Q4 24
$671.3M
$858.9M
Q3 24
$702.0M
$813.0M
Q2 24
$869.5M
$691.7M
Q1 24
$860.0M
$695.1M
Debt / Equity
BOOM
BOOM
HCAT
HCAT
Q4 25
0.21×
0.62×
Q3 25
0.22×
0.46×
Q2 25
0.23×
0.44×
Q1 25
0.29×
1.02×
Q4 24
0.28×
1.05×
Q3 24
0.29×
0.97×
Q2 24
0.20×
Q1 24
0.21×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BOOM
BOOM
HCAT
HCAT
Operating Cash FlowLast quarter
$15.2M
$9.9M
Free Cash FlowOCF − Capex
$9.6M
$9.6M
FCF MarginFCF / Revenue
6.7%
12.9%
Capex IntensityCapex / Revenue
3.9%
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$37.0M
$-697.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BOOM
BOOM
HCAT
HCAT
Q4 25
$15.2M
$9.9M
Q3 25
$18.6M
$-464.0K
Q2 25
$15.2M
$-9.0M
Q1 25
$4.5M
$280.0K
Q4 24
$11.8M
$-3.5M
Q3 24
$19.0M
$6.2M
Q2 24
$2.3M
$1.6M
Q1 24
$13.4M
$10.3M
Free Cash Flow
BOOM
BOOM
HCAT
HCAT
Q4 25
$9.6M
$9.6M
Q3 25
$14.4M
$-719.0K
Q2 25
$12.3M
$-9.2M
Q1 25
$709.0K
$-390.0K
Q4 24
$6.1M
$-3.9M
Q3 24
$12.9M
$5.5M
Q2 24
$-204.0K
$1.3M
Q1 24
$10.5M
$10.1M
FCF Margin
BOOM
BOOM
HCAT
HCAT
Q4 25
6.7%
12.9%
Q3 25
9.5%
-0.9%
Q2 25
7.9%
-11.4%
Q1 25
0.4%
-0.5%
Q4 24
4.0%
-4.9%
Q3 24
8.5%
7.2%
Q2 24
-0.1%
1.7%
Q1 24
6.3%
13.5%
Capex Intensity
BOOM
BOOM
HCAT
HCAT
Q4 25
3.9%
0.4%
Q3 25
2.8%
0.3%
Q2 25
1.9%
0.3%
Q1 25
2.4%
0.8%
Q4 24
3.7%
0.5%
Q3 24
4.0%
0.9%
Q2 24
1.5%
0.4%
Q1 24
1.8%
0.3%
Cash Conversion
BOOM
BOOM
HCAT
HCAT
Q4 25
Q3 25
Q2 25
131.43×
Q1 25
6.63×
Q4 24
39.90×
Q3 24
Q2 24
0.58×
Q1 24
5.24×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BOOM
BOOM

Dyna Energetics Segment$68.9M48%
Other$57.0M40%
Nobel Clad Segment$17.7M12%

HCAT
HCAT

Recurring Technology$51.9M69%
Professional Services$22.8M31%

Related Comparisons